Preclinical testing of drug delivery systems to bone

Adv Drug Deliv Rev. 2015 Nov 1:94:151-64. doi: 10.1016/j.addr.2015.07.006. Epub 2015 Jul 23.

Abstract

Bone defects do not heal in 5-10% of the fractures. In order to enhance bone regeneration, drug delivery systems are needed. They comprise a scaffold with or without inducing factors and/or cells. To test these drug delivery systems before application in patients, they finally need to be tested in animal models. The choice of animal model depends on the main research question; is a functional or mechanistic evaluation needed? Furthermore, which type of bone defects are investigated: load-bearing (i.e. orthopedic) or non-load-bearing (i.e. craniomaxillofacial)? This determines the type of model and in which type of animal. The experiments need to be set-up using the 3R principle and must be reported following the ARRIVE guidelines.

Keywords: Animal model; Bone regeneration; Critical size defect; Large animals; Load-bearing; Non-union; Rat; Sheep.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Regeneration / drug effects*
  • Diphosphonates / administration & dosage
  • Disease Models, Animal*
  • Drug Delivery Systems / methods*
  • Drug Evaluation, Preclinical / methods*
  • Humans
  • Intercellular Signaling Peptides and Proteins / administration & dosage
  • Mesenchymal Stem Cells
  • Tissue Scaffolds

Substances

  • Diphosphonates
  • Intercellular Signaling Peptides and Proteins